High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease

K. Rajender Reddy, Jacqueline G. O'Leary, Patrick S. Kamath, Michael B. Fallon, Scott W. Biggins, Florence Wong, Heather M. Patton, Guadalupe Garcia‐Tsao, Ram M. Subramanian, Leroy R. Thacker, Jasmohan S. Bajaj, for the North American Consortium for the Study of End‐Stage Liver Disease – 4 April 2015 – Because Model for End‐Stage Liver Disease (MELD) scores at the time of liver transplantation (LT) increase nationwide, patients are at an increased risk for delisting by becoming too sick or dying while awaiting transplantation.

Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis

Elliot B. Tapper, Daniel Finkelstein, Murray A. Mittleman, Gail Piatkowski, Michelle Lai – 4 April 2015 – The risk of morbidity and mortality for hospitalized patients with cirrhosis is high and incompletely captured by conventional indices. We sought to evaluate the predictive role of frailty in an observational cohort study of inpatients with decompensated cirrhosis between 2010 and 2013. The primary outcome was 90‐day mortality. Secondary outcomes included discharge to a rehabilitation hospital, 30‐day readmission, and length of stay.

Projections in donor organs available for liver transplantation in the United States: 2014‐2025

Neehar D. Parikh, David Hutton, Wesley Marrero, Kunal Sanghani, Yongcai Xu, Mariel Lavieri – 3 April 2015 – With the aging US population, demographic shifts, and obesity epidemic, there is potential for further exacerbation of the current liver donor shortage. We aimed to project the availability of liver grafts in the United States.

Subscribe to